Advertisement
ProteinSimple
ProteinSimple

The Scientist

» drug development and culture

Most Recent

image: Polypharmacy

Polypharmacy

By | July 1, 2012

Dietary supplements can have serious side effects when mixed with prescription drugs, but not all herb-drug interactions are bad.

14 Comments

image: The Little Cell That Could

The Little Cell That Could

By | July 1, 2012

Critics point out that cell therapy has yet to top existing treatments. Biotech companies are setting out to change that—and prove that the technology can revolutionize medicine.

1 Comment

image: Flower Barcodes

Flower Barcodes

By | June 28, 2012

Wales creates a database of DNA barcodes for all of its native flowering plants, hoping to guide conservation and drug development efforts.

1 Comment

image: NIH Tackles Racism

NIH Tackles Racism

By | June 25, 2012

An advisory committee urges the federal funding agency to take steps to counter racial bias in the granting process.

2 Comments

image: A Plea to the FDA

A Plea to the FDA

By | June 21, 2012

Protesters crash the BIO conference to protest the delayed approval of a breast cancer drug.

2 Comments

image: New FDA Review Process Debated

New FDA Review Process Debated

By | June 20, 2012

Industry experts discuss the agency’s plans to make the drug approval process more transparent.

0 Comments

image: Opinion: On the Up and Up

Opinion: On the Up and Up

By | June 20, 2012

An Amgen executive refutes accusations that the company published misleading results of its mid-90s clinical trial testing an anemia drug.

5 Comments

image: UK Gov’t Supports Open Access Plan

UK Gov’t Supports Open Access Plan

By | June 19, 2012

The UK government releases its recommendation that open access be “the main vehicle for the publication of research,” though it warns of the costs that could entail.

0 Comments

image: Opinion: What’s Wrong with COI?

Opinion: What’s Wrong with COI?

By | June 12, 2012

Financial “conflicts of interest” should not be so quickly condemned. Industry relationships are unequivocally beneficial.

0 Comments

image: FDA OKs Early Stage Trials

FDA OKs Early Stage Trials

By | June 5, 2012

The regulatory agency will allow early-stage breast cancer patients to try experimental drugs previously reserved for those with advanced disease.

1 Comment

Advertisement

Popular Now

  1. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  2. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  3. Simulating Scientific Sabotage, For Fun
  4. Holding Their Ground
    Features Holding Their Ground

    To protect the global food supply, scientists want to understand—and enhance—plants’ natural resistance to pathogens.

Advertisement
Advertisement
Advertisement
Life Technologies